INDV - INDIVIOR PLC
Region: US
Website: www.indivior.com/en
Employees: 0
IPO year: 2014
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Indivior PLC ( LON:INDV ) investors will be delighted, with the company turning in some strong numbers with its latest...
Read moreIndivior Announces Q1 2025 Financial Results
Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending March 31, 2025. The earnings release, investor presentation and webcast are available at www.indivior.com.
Read moreIs Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks’ Oaktree Capital Management?
We recently published a list of 10 Best Stocks to Buy According to Howard Marks’ Oaktree Capital Management. In this article, we are going to take a look at where Indivior PLC (NASDAQ:INDV) stands against other best stocks to buy according to Howard Marks’ Oaktree Capital Management. Howard Marks is an American billionaire and the […]
Read more